Insider · CIK 0001242615

OLUKOTUN ADEOYE Y

Reports to the SEC for 8 companies · PASADENA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001242615

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-18	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,000 sh	$86.96	−$174K	31,600
2026-05-12	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+22.7K sh	—	—	22,700
2025-12-19	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,090 sh	$66.70	−$206K	40,510
2025-12-19	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−6,083 sh	$68.04	−$414K	34,427
2025-12-19	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−827 sh	$68.48	−$56.6K	33,600
2025-12-16	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+7,819 sh	—	—	43,600
2025-05-13	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2025-01-23	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−959 sh	$21.00	−$20.1K	35,781
2024-12-27	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,850 sh	$20.00	−$57K	36,740
2024-12-18	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+16.7K sh	$22.99	+$385K	39,590
2024-06-10	TNXPTonix Pharmaceuticals Holding Corp.J Other	Director	JOther	−0.812 sh	$1.91	−$1.551	0
2024-05-23	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+105K sh	—	—	104,621
2023-12-15	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+15K sh	$25.41	+$381K	22,854
2023-05-08	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+60K sh	—	—	60,000
2023-03-03	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$32.65	−$371K	7,867
2023-01-10	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+7,867 sh	—	—	19,217
2023-01-10	ARWRARROWHEAD PHARMACEUTICALS, INC. · Common StockA Award	Director	AAward	+4,593 sh	—	—	4,593
2022-05-09	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+2.13M sh	—	—	2,131,500
2022-01-07	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+6,400 sh	—	—	11,350
2022-01-03	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,890 sh	$64.26	−$121K	7,110
2022-01-03	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,916 sh	$65.04	−$125K	5,194
2022-01-03	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−244 sh	$66.25	−$16.2K	4,950
2021-09-13	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,250 sh	$63.76	−$143K	11,750
2021-09-13	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,750 sh	$63.76	−$175K	9,000
2021-05-10	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+271K sh	—	—	270,882
2021-01-01	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+9,000 sh	—	—	14,000
2020-08-13	TNXPTonix Pharmaceuticals Holding Corp.P Purchase	Director	PPurchase	+5,350 sh	$0.94	+$5,029	5,350
2020-05-04	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+75K sh	—	—	75,000
2019-05-06	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+30K sh	—	—	30,000
2018-09-05	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+15K sh	—	—	15,000
2013-08-06	Diadexus, Inc.A Award	Director	AAward	+5,958 sh	—	—	5,958
2013-07-31	Diadexus, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+55K sh	—	—	55,000
2013-03-12	BIOCLINICA INCU Disposition from Tender	Director	UDisposition from Tender	−52K sh	$7.25	−$377K	0
2012-05-16	BIOCLINICA INCRestricted Stock UnitsA Award	Director	AAward	+12K sh	—	—	52,000
2011-10-27	ICAGEN INCD Disposition to Issuer	Director	DDisposition to Issuer	−7,062 sh	$6.00	−$42.4K	0
2011-09-02	ICAGEN INCM Exercise/Conversion	Director	MExercise/Conversion	+1,250 sh	$3.36	+$4,200	14,953
2011-09-02	ICAGEN INCM Exercise/Conversion	Director	MExercise/Conversion	+1,250 sh	$4.08	+$5,100	16,203
2011-09-02	ICAGEN INCM Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	$2.56	+$5,120	18,203
2011-09-02	ICAGEN INCDirector Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+1,250 sh	—	—	0
2011-09-02	ICAGEN INCDirector Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+1,250 sh	—	—	0
2011-09-02	ICAGEN INCDirector Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	—	—	0
2011-09-02	ICAGEN INCU Disposition from Tender	Director	UDisposition from Tender	−11.1K sh	$6.00	−$66.8K	7,062
2011-06-03	ICAGEN INCDirector Stock Option (right to buy)A Award	Director	AAward	+2,000 sh	—	—	2,000
2011-05-11	BIOCLINICA INCRestricted Stock UnitsA Award	Director	AAward	+10K sh	—	—	40,000
2011-01-03	ICAGEN INCA Award	Director	AAward	+7,062 sh	—	—	13,703
2010-06-04	ICAGEN INCDirector Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2010-05-12	BIOCLINICA INCRestricted Stock UnitsA Award	Director	AAward	+10K sh	—	—	30,000
2010-01-04	ICAGEN INCA Award	Director	AAward	+26.5K sh	—	—	53,134
2009-07-08	BIOCLINICA INCRestricted Stock UnitsA Award	Director	AAward	+10K sh	—	—	20,000
2009-06-03	ICAGEN INCDirector Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Aug 204
OLUKOTUN ADEOYE Y0001242615-26-000002
SEC(opens sec.gov)
May 144
OLUKOTUN ADEOYE Y0001999371-26-010753
SEC(opens sec.gov)
Dec 234
OLUKOTUN ADEOYE Y0001242615-25-000006
SEC(opens sec.gov)
Dec 184
OLUKOTUN ADEOYE Y0001242615-25-000004
SEC(opens sec.gov)
May 154
OLUKOTUN ADEOYE Y0001999371-25-006242
SEC(opens sec.gov)
Feb 284
OLUKOTUN ADEOYE Y0001839882-25-012471
SEC(opens sec.gov)
Jan 274
OLUKOTUN ADEOYE Y0001628280-25-002716
SEC(opens sec.gov)
Dec 304
OLUKOTUN ADEOYE Y0001628280-24-052592
SEC(opens sec.gov)
Dec 204
OLUKOTUN ADEOYE Y0001628280-24-052273
SEC(opens sec.gov)
May 244
OLUKOTUN ADEOYE Y0001999371-24-006622
SEC(opens sec.gov)
Dec 194
OLUKOTUN ADEOYE Y0001628280-23-041966
SEC(opens sec.gov)
May 104
OLUKOTUN ADEOYE Y0001839882-23-012502
SEC(opens sec.gov)
Mar 64
OLUKOTUN ADEOYE Y0001209191-23-016446
SEC(opens sec.gov)
Jan 114
OLUKOTUN ADEOYE Y0001209191-23-003071
SEC(opens sec.gov)
May 114
OLUKOTUN ADEOYE Y0001387131-22-006015
SEC(opens sec.gov)
Jan 74
OLUKOTUN ADEOYE Y0001209191-22-002593
SEC(opens sec.gov)
Jan 44
OLUKOTUN ADEOYE Y0001209191-22-001328
SEC(opens sec.gov)

Companies

Address

177 E COLORADO BLVD STE 700

PASADENA, CA, 91105